John E. Kao Sells 180,000 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John E. Kao sold 180,000 shares of Alignment Healthcare stock in a transaction that occurred on Thursday, July 10th. The shares were sold at an average price of $13.41, for a total value of $2,413,800.00. Following the sale, the chief executive officer directly owned 1,553,100 shares in the company, valued at approximately $20,827,071. This trade represents a 10.39% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Alignment Healthcare Trading Down 0.1%

NASDAQ ALHC traded down $0.01 on Friday, hitting $13.37. 1,667,656 shares of the company were exchanged, compared to its average volume of 2,223,800. The company has a debt-to-equity ratio of 2.95, a current ratio of 1.69 and a quick ratio of 1.69. Alignment Healthcare, Inc. has a twelve month low of $7.92 and a twelve month high of $21.06. The firm has a market capitalization of $2.65 billion, a P/E ratio of -27.85 and a beta of 1.16. The company's 50 day moving average price is $14.70 and its 200-day moving average price is $15.21.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.12) by $0.07. The company had revenue of $926.93 million during the quarter, compared to analyst estimates of $889.83 million. Alignment Healthcare had a negative return on equity of 80.49% and a negative net margin of 3.02%. The company's revenue for the quarter was up 47.5% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.25) earnings per share. Analysts predict that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Institutional Trading of Alignment Healthcare

Several institutional investors have recently made changes to their positions in ALHC. MCF Advisors LLC increased its position in Alignment Healthcare by 87.6% in the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company's stock worth $40,000 after purchasing an additional 1,011 shares during the last quarter. Skandinaviska Enskilda Banken AB publ bought a new position in shares of Alignment Healthcare during the 1st quarter valued at $42,000. Amalgamated Bank boosted its holdings in Alignment Healthcare by 21.6% in the first quarter. Amalgamated Bank now owns 3,466 shares of the company's stock worth $65,000 after purchasing an additional 616 shares in the last quarter. RiverPark Advisors LLC acquired a new position in Alignment Healthcare during the fourth quarter worth $106,000. Finally, Tower Research Capital LLC TRC raised its holdings in Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company's stock valued at $119,000 after buying an additional 6,286 shares in the last quarter. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on ALHC shares. Robert W. Baird lifted their target price on Alignment Healthcare from $17.00 to $22.00 and gave the company an "outperform" rating in a research note on Tuesday, April 15th. Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. Stifel Nicolaus increased their price objective on shares of Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a report on Tuesday, April 8th. Finally, UBS Group boosted their target price on Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a report on Friday, May 2nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Alignment Healthcare presently has an average rating of "Moderate Buy" and an average target price of $17.17.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.